P

Inventor

WASLEY JAN W F

US33 patents
⚠️ This page may combine multiple inventors who share the name “WASLEY JAN W F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEUROGEN CORP

15 patents
US6245768B1Jun 12, 2001

1-(N′-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands

NEUROGEN CORP31 citations92
US6031097AFeb 29, 2000

1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands

NEUROGEN CORP5 citations73
US5744472AApr 28, 1998

1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands

NEUROGEN CORP7 citations73
US5656632AAug 12, 1997

1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligands

NEUROGEN CORP6 citations73
US5602168AFeb 11, 1997

1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligands

NEUROGEN CORP9 citations73
US6040448AMar 21, 2000

Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands

NEUROGEN CORP10 citations71
US5760234AJun 2, 1998

Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands

NEUROGEN CORP3 citations63
US5750700AMay 12, 1998

Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands

NEUROGEN CORP2 citations63
US6252077B1Jun 26, 2001

1-(N′-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands

NEUROGEN CORP1 citations62
US5932729AAug 3, 1999

1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands

NEUROGEN CORP3 citations62
US6384224B2May 7, 2002

Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines; dopamine receptor subtype specific ligands

NEUROGEN CORP3 citations60
US6331629B1Dec 18, 2001

Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines; dopamine receptor subtype specific ligands

NEUROGEN CORP3 citations60
US6034252AMar 7, 2000

Substituted thienocycloalkylpyrazoles: dopamine receptor subtype specific ligands

NEUROGEN CORP0 citations52
US6002005ADec 14, 1999

Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands

NEUROGEN CORP1 citations52
US6441175B1Aug 27, 2002

1-(N'-arylalkylaminoalkyl)aminoisoquinolines: a new class of dopamine receptor subtype

NEUROGEN CORP0 citations51

CIBA GEIGY CORP

13 patents

HELICON THERAPEUTICS INC

2 patents

KAPLAN ALAN P

2 patents

(unassigned)

1 patent